 [3] 
  Searle Canada Inc. filed a Counterstatement dated May 3rd, 1994, denying the grounds of opposition. An amended application was subsequently filed on September 8th, 1995, wherein the wares covered by the application as approved and advertised, namely 200 mg of misoprostol was revised to read 200 mcg of misoprostol. In 1994 Monsanto Canada, Inc. acquired the assets of Searle Canada Inc. and the application for registration of the proposed trademark was transferred to the respondent's name on April 28, 1995. 
